World Courier network meets GxP requirements

By Staff reporter

- Last updated on GMT

Related tags World courier Quality assurance

World Courier has GxP compliant status for its whole distribution network, covering more than 140 offices in 50 countries, which it believes no other business in the sector has achieved on such a large scale.

The globalisation of pharmaceutical clinical trials, leading to many trial sites being located in developing countries, has placed new pressures on distribution networks and increased the need for proper handling of time- and temperature-sensitive transport.

To meet these evolving needs World Courier has formalised its GxP (good distribution / manufacturing / storage / clinical practice) compliance by taking several measures.

These include the development of a company-wide GxP policy, implementation of processes to enhance its ISO 9001 programme and the appointment of a global quality assurance (QA) team to ensure compliance on local, regional and corporate levels.

World Courier believes that by adopting an integrated, company wide approach it can ensure that all aspects of a client’s pharmaceutical storage and transport needs are safeguarded.

This spans temperature controlled transport of investigational drugs, biological samples and ancillary supplies to and from research sites, as well as the storage and distribution of materials from its 11 GMP-compliant drug depots.

Furthermore, World Courier aims to ensure the quality of its temperature controlled operations by employing experts who recommend the appropriate packaging from a range of thermal containment offerings.

The compliance of all these operations is monitored by the global QA team to ensure standards are maintained from start to finish. Wayne Heyland, president of the World Courier group, added that the company will continue to improve its processes.

He explained that “as the concept of 'quality' continues to evolve, our mission is to ensure that we evolve with it, and that we continue to lead – not follow – industry standards in this critical area​”.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more